Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00447499 · ClinicalTrials.gov registry record · Phase 3
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
A Phase 3 study, sponsored by Ipsen.
- Completed
- Registry status
- Phase 3
- Development phase
- 59
- Enrollment target
NCT00447499 is a Phase 3 study that has completed, run by Ipsen. The registered enrollment target is 59 participants.
The verdict
NCT00447499, a Phase 3 study, has completed, sponsored by Ipsen.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 59 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether subjects with acromegaly (or their partners) are able to self administer Somatuline Autogel at home.
Interventions
- DRUG Somatuline Autogel (lanreotide acetate)
- BEHAVIORAL Home administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2007-04 |
| Est. Completion | 2008-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00447499
The ClinicalTrials.gov registry entry for NCT00447499 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ipsen, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Somatuline Autogel (lanreotide acetate) is the first listed.
NCT00447499 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00447499 about?
NCT00447499 is a clinical study titled "Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel". The purpose of this study is to determine whether subjects with acromegaly (or their partners) are able to self administer Somatuline Autogel at home.
What is the current status of trial NCT00447499?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 59 participants. The study started on 2007-04. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00447499?
The interventions under investigation include: Somatuline Autogel (lanreotide acetate) (DRUG), Home administration (BEHAVIORAL).
Who is sponsoring clinical trial NCT00447499?
This trial is sponsored by Ipsen, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.